After participating in this educational activity, attendees should be able to:
- Describe challenges of buprenorphine initiations in the fentanyl era
- Explain Low dose buprenorphine
- List low dose buprenorphine strategies
Gene Lambert, MD, MBA, FACP, FASAM
Medical Director, Addiction Consult Team, Substance Use Disorders Initiative, Massachusetts General Hospital
Faculty, Program in Substance Use and Addiction Services, Department of Medicine, Massachusetts General Hospital
Instructor of Medicine, Harvard Medical School
The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Baystate Continuing Interprofessional Education designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
- 1.25 AMA PRA Category 1 Credit™
- 1.25 BCIPE Instructional Hours